Literature DB >> 7275529

An animal model for cicatrizing trachoma.

H R Taylor, R A Prendergast, C R Dawson, J Schachter, A M Silverstein.   

Abstract

An animal model of cicatrizing trachoma was developed in cynomolgus monkeys. This model is consistent with our hypothesis that repeated ocular inoculation of Chlamydia trachomatis, BOUR strain, mimics the repeated reinfection that occurs naturally in endemic human trachoma. A chronic follicular conjunctivitis developed, and scarring later appeared in the superior tarsal conjunctiva. The organism was reisolated after the infection and was also demonstrated cytologically. Specific antichlamydial antibodies of both the IgM and IgG types appeared in the sera of the monkeys. Histopathologic examination of conjunctiva showed a marked lymphocytic response and the presence of germinal centers; areas of conjunctival scar tissue were also examined. Efforts to produce a similar model in rhesus monkeys were less successful.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7275529

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

1.  Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection.

Authors:  J A Whittum-Hudson; H R Taylor
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

2.  Conjunctival lymphocyte subsets in trachoma.

Authors:  E M Burd; K F Tabbara; A M Nasr; P B Taylor
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

3.  Reactivation of chlamydial genital tract infection in mice.

Authors:  T W Cotter; G S Miranpuri; K H Ramsey; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

5.  An in vitro model for immune control of chlamydial growth in polarized epithelial cells.

Authors:  J U Igietseme; P B Wyrick; D Goyeau; R G Rank
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Tear and serum antibody response to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting.

Authors:  H D Caldwell; S Stewart; S Johnson; H Taylor
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

7.  Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.

Authors:  Laszlo Kari; William M Whitmire; Deborah D Crane; Nathalie Reveneau; John H Carlson; Morgan M Goheen; Ellena M Peterson; Sukumar Pal; Luis M de la Maza; Harlan D Caldwell
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

8.  A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic.

Authors:  A D Murdin; H Su; D S Manning; M H Klein; M J Parnell; H D Caldwell
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Demonstration of chlamydial RNA and DNA during a culture-negative state.

Authors:  S M Holland; A P Hudson; L Bobo; J A Whittum-Hudson; R P Viscidi; T C Quinn; H R Taylor
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

10.  Effect of bacterial secondary infection in an animal model of trachoma.

Authors:  H R Taylor; R A Kolarczyk; S L Johnson; J Schachter; R A Prendergast
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.